Topical 0.1% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: a pilot study of four patients.
第一作者:
Rachael S,Foster
第一单位:
Department of Paediatric Dermatology, Princess Margaret Hospital for Children, Subiaco, Western Australia, Australia. rachael.foster@health.wa.gov.au
作者:
医学主题词
投药, 局部(Administration, Topical);青少年(Adolescent);血管纤维瘤(Angiofibroma);抗生素类, 抗肿瘤(Antibiotics, Antineoplastic);儿童(Child);儿童, 学龄前(Child, Preschool);面部肿瘤(Facial Neoplasms);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);男(雄)性(Male);试点项目(Pilot Projects);西罗莫司(Sirolimus);治疗结果(Treatment Outcome);结节性硬化症(Tuberous Sclerosis)
DOI
10.1111/j.1440-0960.2011.00837.x
PMID
22309333
发布时间
2013-11-21
- 浏览34
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



